Factors Related to Regional Recurrence in Early Stage Squamous Cell Carcinoma of the Oral Tongue
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. This study analyzed various clinical and histopathologic factors for patients with early stage squamous cell carcinoma (SCC) of the oral tongue to define a high risk group for regional recurrence and finally to find out the indication of elective neck dissection (END). Methods. Retrospective chart review was performed for 63 patients with T1-T2N0 SCC of the oral tongue who underwent partial glossectomy with/without END. Clinical and histopathologic factors assessed were age, gender, clinical T stage, tumor cell differentiation, depth of invasion, pathologic nodal status, and intrinsic muscle involvement, perineural invasion, lymphovascular emboli and resection margin involvement. Results. Five year overall survival rate was 97.1% in stage I and 76.2% in stage II, and 5-yr disease free survival rate was 76.7% in stage I and 43.5% in stage II. Rates of occult nodal metastasis in stage I and II were 15.4% and 42.9%, respectively. Overall regional recurrence rate was 15.9%, which consisted of 10.2% in stage I and 35.7% in stage II. The success rate of salvage treatment was 100% in stage I and 40% in stage II. Higher T stage, higher histologic grade, depth of invasion ≥3 mm, presence of intrinsic muscle involvement were significantly related to regional recurrence (P=0.035, P=0.011, P=0.016, P=0.009, respectively). In stage I, the non-END group (n=36) showed 13.9% of regional recurrence rate, while END group (n=13) did not have any regional recurrence (P=0.198). Five year disease free survival rate of END group was significantly higher than non-END group (100% and 68.7%, respectively, P=0.045). Conclusion. We recommend to perform END in early stage SCC of the oral tongue if the primary tumor has T2 stage, and T1 stage with higher histologic grade, depth of invasion more than 3 mm, or presence of intrinsic muscle involvement.
Abstract
Objectives. This study analyzed various clinical and histopathologic factors for patients with early stage squamous cell carcinoma (SCC) of the oral tongue to define a high risk group for regional recurrence and finally to find out the indication of elective neck dissection (END). Methods. Retrospective chart review was performed for 63 patients with T1-T2N0 SCC of the oral tongue who underwent partial glossectomy with/without END. Clinical and histopathologic factors assessed were age, gender, clinical T stage, tumor cell differentiation, depth of invasion, pathologic nodal status, and intrinsic muscle involvement, perineural invasion, lymphovascular emboli and resection margin involvement. Results. Five year overall survival rate was 97.1% in stage I and 76.2% in stage II, and 5-yr disease free survival rate was 76.7% in stage I and 43.5% in stage II. Rates of occult nodal metastasis in stage I and II were 15.4% and 42.9%, respectively. Overall regional recurrence rate was 15.9%, which consisted of 10.2% in stage I and 35.7% in stage II. The success rate of salvage treatment was 100% in stage I and 40% in stage II. Higher T stage, higher histologic grade, depth of invasion ≥3 mm, presence of intrinsic muscle involvement were significantly related to regional recurrence (P=0.035, P=0.011, P=0.016, P=0.009, respectively). In stage I, the non-END group (n=36) showed 13.9% of regional recurrence rate, while END group (n=13) did not have any regional recurrence (P=0.198). Five year disease free survival rate of END group was significantly higher than non-END group (100% and 68.7%, respectively, P=0.045). Conclusion. We recommend to perform END in early stage SCC of the oral tongue if the primary tumor has T2 stage, and T1 stage with higher histologic grade, depth of invasion more than 3 mm, or presence of intrinsic muscle involvement.
참고문헌 (18)
- Yuen AP, "Elective neck dissection versus observation in the treatment of early oral tongue carcinoma", Head Neck, 19(7), pp.583~588 (1997)
- Haddadin KJ, "Improved survival for patients with clinically T1", T2, N0 tongue tumors undergoing a prophylactic neck dissection, 1999, pp.21(6), 517~525
- Keski-Santti H, "Elective neck treatment versus observation in patients with T1", T2 N0 squamous cell carcinoma of oral tongue, 2006, pp.42(1), 96~101
- Teichgraeber JF, "The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale", Head Neck Surg, 7(1), pp.15~21 (1984)
- 임영창, "조기 구강설 편평세포암종의 잠재적 경부림프절 전이", 대한이비인후과학회지 두경부외과학, 49(4), pp.407~410 (2006), 대한이비인후과학회
- Yii NW, "Management of the N0 neck in early cancer of the oral tongue", Clin Otolaryngol Allied Sci, 24(1), pp.75~79 (1999)
- Spiro RH, "Surgical treatment of cancer of the tongue", Surg Clin North Am, 54(4), pp.759~765 (1974)
- Kligerman J, "Supraomohyoid neck dissection in the treatment of T1", T2 squamous cell carcinoma of oral cavity, 1994, pp.168(5), 391~394
- Kaya S, "The value of elective neck dissection in treatment of cancer of the tongue", Am J Otolaryngol, 22(1), pp.59~64 (2001)
- Sparano A, "Multivariate predictors of occult neck metastasis in early oral tongue cancer", Otolaryngol Head Neck Surg, 131(4), pp.472~476 (2004)
- Keski-Santti H, "Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue", Oral Oncol, 43(10), pp.1007~1013 (2007)
- Fakih AR, "Elective versus therapeutic neck dissection in early carcinoma of the oral tongue", Am J Surg, 158(4), pp.309~313 (1989)
- Dias FL, "Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth", Otolaryngol Head Neck Surg, 125(1), pp.23~29 (2001)
- Friedlander PL, "Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis", Head Neck, 20(5), pp.363~368 (1998)
- Davidson BJ, "Age and survival from squamous cell carcinoma of the oral tongue", Head Neck, 23(4), pp.273~279 (2001)
- Fukano H, "Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma", Head Neck, 19(3), pp.205~210 (1997)
- O’Brien CJ, "Tumor thickness influences prognosis of T1 and T2 oral cavity cancer--but what thickness?", Head Neck, 25(11), pp.937~945 (2003)
- Wei WI, "Management of the N0 neck--reference or preference", Oral Oncol, 42(2), pp.115~122 (2006)